CytoSorbents holds annual shareholder meeting

• CytoSorbents held its annual shareholder meeting on Aug. 13, 2026.
• Shareholders backed a charter amendment authorizing a reverse stock split, with the board to set a ratio between 1-for-5 and 1-for-20 within one year.
• Holders ratified WithumSmith+Brown as independent registered public accounting firm for the year ending Dec. 31, 2026.
• Investors also authorized an adjournment if needed to solicit more proxies, though no adjournment was required.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoSorbents Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-097092), on August 14, 2026, and is solely responsible for the information contained therein.